|
ZWILCH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.657600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.708550E-01 |
| Normal-vs-Stage2 |
2.673800E-01 |
| Normal-vs-Stage3 |
1.079000E-01 |
| Normal-vs-Stage4 |
2.197200E-01 |
| Stage1-vs-Stage2 |
7.099000E-01 |
| Stage1-vs-Stage3 |
3.000600E-01 |
| Stage1-vs-Stage4 |
5.226800E-01 |
| Stage2-vs-Stage3 |
6.773000E-01 |
| Stage2-vs-Stage4 |
7.530000E-01 |
| Stage3-vs-Stage4 |
9.605000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.318400E-03 |
| Normal-vs-AfricanAmerican |
3.560400E-01 |
| Normal-vs-Asian |
4.605800E-01 |
| Caucasian-vs-AfricanAmerican |
5.896200E-02 |
| Caucasian-vs-Asian |
6.827400E-01 |
| AfricanAmerican-vs-Asian |
8.718400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.495900E-02 |
| Normal-vs-Female |
2.315100E-03 |
| Male-vs-Female |
7.943900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.677800E-01 |
| Normal-vs-Extreme_Weight |
3.033000E-01 |
| Normal-vs-Obese |
5.197100E-03 |
| Normal-vs-Extreme_Obese |
9.322200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.529000E-01 |
| Normal_Weight-vs-Obese |
5.837600E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.519000E-01 |
| Extreme_Weight-vs-Obese |
4.927600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.714200E-01 |
| Obese-vs-Extreme_Obese |
1.521560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.692000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.719680E-03 |
| Normal-vs-Age(61-80Yrs) |
5.438300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.665000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.146000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.497800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.275650E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.643200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.114300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.844200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.756900E-04 |
| Normal-VS-Type2 PRCC |
2.258200E-01 |
| Normal-VS-KIRP CIMP |
4.436200E-03 |
| Normal-VS-Unclassified PRCC |
1.658570E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.78879999987747E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.422430E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.970400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.16970000036454E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.633620E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.099100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.312200E-01 |
| Normal-vs-N1 |
8.405000E-03 |
| Normal-vs-N2 |
8.763800E-01 |
| N0-vs-N1 |
7.161500E-03 |
| N0-vs-N2 |
8.493400E-01 |
| N1-vs-N2 |
2.750400E-01 |
|
|
